Discover how CRISPR-based therapy could revolutionize HPAI treatment in poultry, offering farmers a lifesaving alternative to complete flock depopulation and preventing costly outbreaks.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its ...

Rice University researchers have developed a CRISPR-based gene activation strategy that boosts mitochondrial production in damaged heart cells, improving cardiac function after heart attacks in both ...

CRISPR Therapeutics AG CRSP shares moved lower Tuesday after the biotechnology company outlined plans to raise capital through a new convertible debt offering. The gene-editing firm said it intends to ...

I still remember the first time I saw a smartphone, back in 2007, at a tech conference in Berlin. A colleague, Markus, pulled ...

Over the past two decades, cell biologists and computational biologists have worked to develop lineage tracing techniques that can decode the ...

The Women’s Industry Network (WIN) has announced the recipients of its 2026 Most Influential Women (MIW) awards, which ...

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, United States College of Health Solutions, Arizona State University, Phoenix, United States ...

Through bi-parental genetic mapping and high-quality DNA sequencing analysis, the research team identified naturally occurring allelic variants of the GmSNAP14 gene in resistant soybean lines, ...

NextEra Energy ( (NEE)) just unveiled an update. On March 5, 2026, NextEra Energy said Executive Vice President and Chief Risk Officer Terrell Kirk Crews II had notified the company he will resign, ...

Kansas State University researchers have unveiled an innovative approach to fighting highly pathogenic avian influenza (HPAI) that could revolutionize poultry health management. The solution?

Bank of America Securities analyst Alec Stranahan reiterated a Sell rating on Erasca today and set a price target of $2.00. Stranahan covers the Healthcare sector, focusing on stocks such as Novavax, ...